Free Trial

Givaudan (OTCMKTS:GVDNY) Sees Unusually-High Trading Volume - Here's What Happened

Givaudan logo with Basic Materials background

Key Points

  • Givaudan SA experienced a significant increase in trading volume, with 108,741 shares changing hands, marking a 261% increase from the previous day's volume.
  • Barclays upgraded Givaudan's rating from "strong sell" to "hold", contributing to an overall average rating of "Moderate Buy" from analysts.
  • The company's current trading price is $85.49, slightly up from the previous close of $85.44, amidst fluctuations in its moving averages.
  • Five stocks to consider instead of Givaudan.

Shares of Givaudan SA (OTCMKTS:GVDNY - Get Free Report) saw an uptick in trading volume on Thursday . 108,741 shares changed hands during mid-day trading, an increase of 261% from the previous session's volume of 30,163 shares.The stock last traded at $85.49 and had previously closed at $85.44.

Analyst Ratings Changes

Separately, Barclays raised shares of Givaudan from a "strong sell" rating to a "hold" rating in a research note on Tuesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy".

Get Our Latest Report on Givaudan

Givaudan Stock Performance

The company's 50 day moving average is $88.10 and its 200-day moving average is $92.04. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.98 and a current ratio of 1.49.

About Givaudan

(Get Free Report)

Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Givaudan Right Now?

Before you consider Givaudan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.

While Givaudan currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.